NCT04261959

Brief Summary

Marginalized populations are at increased risk of chronic pain, trauma and use of street drugs to manage this suffering, with the associated risk of overdoses. Non-pharmacological options to manage chronic pain are difficult for this population to access. myoActivation® is an innovative structured assessment and therapeutic approach. This study will be conducted in the Vancouver Community Pain Service and will will examine the impact of this treatment on pain outcomes, function and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 3, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 10, 2020

Completed
8 days until next milestone

Study Start

First participant enrolled

February 18, 2020

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 2, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 2, 2022

Completed
Last Updated

September 16, 2025

Status Verified

November 1, 2022

Enrollment Period

2.5 years

First QC Date

February 3, 2020

Last Update Submit

September 9, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • PEG score wk 4

    PEG is a validated self-report measure of (1) Pain intensity, (2) interference with Enjoyment of life, (3) interference with General activity. Each of the 3 dimensions is scored on a 0-10 scale. Total score is the average (mean) of the 3 values, minimum 0, maximum 10, lower score indicates a better outcome.

    4 weeks

  • PEG score wk 12

    PEG is a validated self-report measure of (1) Pain intensity, (2) interference with Enjoyment of life, (3) interference with General activity. Each of the 3 dimensions is scored on a 0-10 scale. Total score is the average (mean) of the 3 values, minimum 0, maximum 10, lower score indicates a better outcome.

    12 weeks

  • PEG score wk 24

    PEG is a validated self-report measure of (1) Pain intensity, (2) interference with Enjoyment of life, (3) interference with General activity. Each of the 3 dimensions is scored on a 0-10 scale. Total score is the average (mean) of the 3 values, minimum 0, maximum 10, lower score indicates a better outcome.

    24 weeks

Secondary Outcomes (9)

  • PCS score wk 4

    4 weeks

  • PCS score wk 12

    12 weeks

  • PCS score wk 24

    24 weeks

  • PSEQ score wk 4

    4 weeks

  • PSEQ score wk 12

    12 weeks

  • +4 more secondary outcomes

Study Arms (1)

myoActivation and other pain services

Participants who receive one or more sessions of myoActivation. They may receive 1:1 counselling and physiotherapy also.

Other: myoActivation

Interventions

myoActivation is a novel, structured assessment and non-pharmacological therapeutic approach to both diagnosis and treatment of chronic myofascial pain. A detailed history of the timeline of lifetime trauma combined with a quick, structured and reproducible set of posture and movement tests help to easily identify myofascial components of chronic pain. The therapeutic component is delivered utilizing a needling technique, or myofascial release, focused to active myofascial trigger points, fascia in tension and tethered scars.

myoActivation and other pain services

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Structurally vulnerable persons (i.e. within marginalized populations) with chronic pain, and typically also mental health issues, substance use disorders, physical and emotional trauma.

You may qualify if:

  • Any English-speaking patient with myofascial related chronic pain lasting \>3 months, referred to the Vancouver Community (VC) chronic pain service by primary care.

You may not qualify if:

  • Any patient who has received any of the following pain interventions or treatment in the 3 months preceding recruitment/intake to the pain service:
  • Intramuscular Stimulation (IMS);
  • Trigger Point Injection (TPI) with or without injectate;
  • External physiotherapy (i.e. outside the service offered at VC pain clinic);
  • Massage;
  • Joint injection;
  • Chiropractic;
  • Acupuncture;
  • Group counselling at VC Pain Service (or has an existing appointment to attend Group counselling).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vancouver Community Pain Service, 524 East Pender Street

Vancouver, British Columbia, V6A 1V3, Canada

Location

Related Publications (1)

  • Nguyen L, Eddy BL, West N, Bone JN, Currie LM, Lauder G. The Impact of a Novel Methodological Process for Needling Scars, Fascia, and Muscles in the Management of Myofascial Dysfunction and Chronic Pain in a Population Living With Social and Health Inequities: Quantitative Findings From a Longitudinal Observational Pilot Study. Pain Res Manag. 2025 Sep 28;2025:8567447. doi: 10.1155/prm/8567447. eCollection 2025.

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Barbara Eddy

    Vancouver Coastal Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Member in the UBC Department of Medicine, Division of Palliative Care

Study Record Dates

First Submitted

February 3, 2020

First Posted

February 10, 2020

Study Start

February 18, 2020

Primary Completion

August 2, 2022

Study Completion

August 2, 2022

Last Updated

September 16, 2025

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations